Replimune (REPL) Share-based Compensation (2017 - 2025)
Replimune has reported Share-based Compensation over the past 9 years, most recently at $7.0 million for Q4 2025.
- Quarterly results put Share-based Compensation at $7.0 million for Q4 2025, down 18.43% from a year ago — trailing twelve months through Dec 2025 was $32.4 million (down 6.52% YoY), and the annual figure for FY2025 was $35.0 million, up 2.69%.
- Share-based Compensation reached $7.0 million in Q4 2025 per REPL's latest filing, down from $8.3 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $9.5 million in Q2 2024 and bottomed at $3.5 million in Q1 2021.
- Median Share-based Compensation over the past 5 years was $7.6 million (2022), compared with a mean of $7.5 million.
- The largest annual shift saw Share-based Compensation surged 153.24% in 2021 before it dropped 18.43% in 2025.
- Over 5 years, Share-based Compensation stood at $5.9 million in 2021, then grew by 18.67% to $7.0 million in 2022, then increased by 17.33% to $8.2 million in 2023, then increased by 4.84% to $8.6 million in 2024, then decreased by 18.43% to $7.0 million in 2025.
- Business Quant data shows Share-based Compensation for REPL at $7.0 million in Q4 2025, $8.3 million in Q3 2025, and $8.8 million in Q2 2025.